Department of Pharmaceutical Analysis, CMR College of Pharmacy, Hyderabad, India- 501401.
A rapid and precise reverse-phase high-performance liquid chromatographic method has been developed for the validation of Metformin and Saxagliptin, in their pure form as well as in tablet dosage form. Chromatography was carried out on an X terra C18 (4.6 x 150mm, 5µm) column using a mixture of ACN, Methanol, and Water (35:50:15 v/v) as the mobile phase at a flow rate of 1.0ml/min, the detection was carried out at 250nm. The method produces linear responses in the concentration range of 25-125ppm of Metformin and 10-50ppm of Saxagliptin. The method precision for the determination of assay was below 2.0 %RSD. The method is useful in the quality control of bulk and pharmaceutical formulations.
Saxagliptin HCl (SAG), (Fig. 1a) is chemically named as (1S,3S,5S)-2-[(2S)-2- amino-2-(3-hydroxy-1-adamantyl)acetyl]- 2-azabicyclo[3.1.0]hexane-3-carbonitrile hydrochloride [1]. Saxagliptin HCl (SAG) is an oral hypoglycemic (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. SAG is used as monotherapy or in combination with other medicines for the treatment of type II diabetes. The drug works to competitively inhibit a protein/enzyme, dipeptidyl peptidase 4 (DPP-4), that results in an increased amount of active incretins; Gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), reduced amount of
release of glucagon and increased release of insulin [2], [3].
Fig. No: 1 Structure of Saxagliptin
Fig. No: 2 Structure of Metformin
Metformin hydrochloride (MET), (Fig. 2b) is chemically designated as 1,1- Dimethyl biguanide hydrochloride [1]. Metformin hydrochloride (MET) is a biguanide antidiabetic. It is given orally
MATERIALS AND METHODS
in the treatment of type II diabetes mellitus; a disease characterized by defects in both insulin secretion and insulin sensitivity, and is the drug of first choice in overweight patients [2]. SAG is not an official drug in any pharmacopeia. While MET was determined by British Pharmacopoeia (BP) [4] and United States Pharmacopeia (USP) [5], both suggest a nonaqueous titration method for the assay of MET using anhydrous formic acid as a solvent and 0.1 M perchloric acid as a titrant. The end point is determined potentiometrically.
Table 1: Drug details
S. No |
Drug name |
Formulation |
Manufacturer |
Procurement |
1 |
Metformin |
_ |
_ |
Procured from sun pharma, provided by Sura labs |
2 |
Saxagliptin |
_ |
_ |
Procured from sun pharma, provided by Sura labs |
Table 2: Instruments and Equipment
S. No |
Instruments |
Software |
Model |
Company |
1 |
HPLC |
Empower 2 |
Alliance 2695 separation module. 996 PDA detector. |
Waters |
2 |
Weighing Balance |
N/A |
XEX 200 |
Sartorius |
3 |
Sonicator |
N/A |
SE60US |
Labman |
Preparation of sample stock solution: Weighed 50mg of Emtricitabine, 6.25mg of tenofovir, and 12.5mg of Bictegravir working std 50ml volumetric flask, add 1oml of diluent, sonicate for 10min and make up to the final volume with diluents.(1000?g/Emtricitabine and 125 ?g/ml and Tenofovir and 250?g/ml of Bictegravir) Preparation of sample stock solution: 5 tablets of average equivalent average taken in 100ml of volumetric flask add diluents sonicate filter it (1000?g/mlEmtricitabine and 125 ?g/ml Tenofovir and 250?g/ml of Bictegravir.
Table 3: Chemicals and Reagents
S. No |
Chemical |
Brand names |
1 |
Water for HPLC |
LICHROSOLV (MERCK) |
2 |
Methanol for HPLC |
LICHROSOLV (MERCK |
3 |
Acetonitrile for HPLC |
Merck |
RESULTS AND DISCUSSION:
Method Development
Table 5: Observation of Optimized Chromatogram
S.No |
Peak Name |
Retention Time |
Area |
Height |
USP Tailing |
USP Plate Count |
USP Resolution |
1 |
Saxagliptin |
1.694 |
1429524 |
364752 |
1.23 |
6993 |
10.69 |
2 |
Metformin |
3.234 |
300414 |
53626 |
1.12 |
5735 |
Concentration ?g/ml |
Average Peak Area |
12.5 |
504954 |
25 |
958753 |
37.5 |
1426583 |
50 |
1845498 |
62.5 |
2272948 |
Table 9: Linearity Observation of Metformin
Concentration ?g/ml |
Average Peak Area |
10 |
107359 |
20 |
191497 |
30 |
300389 |
40 |
388105 |
50 |
490352 |
Optimized chromatographic conditions
Table 6: Shows Optimized chromatographic conditions
Parameter |
Optimized Chromatographic Conditions |
Mobile phase: |
Methanol: Acetonitrile: Water (50:35:15%v/v) |
Column : |
X-Terra (4.6 ×150mm, 5µm particle size) |
Flow rate : |
1ml/min |
Diluent |
Methanol: Acetonitrile: Water (50:35:15%v/v) |
Injection Volume |
10 µl |
Wavelength: |
250 nm |
Column temp: |
35ºC |
Run mode |
Isocratic |
Runtime |
8minutes |
CONCLUSION:
The analytical method was developed by studying different parameters. First of all, the maximum absorbance was found to be at 250nm and the peak purity was excellent. Injection volume was selected to be 10µl which gave a good peak area. The column used for the study was X terra C18 because it gave a good peak. 35 º C temperatures were found to be suitable for the nature of the drug solution. The flow rate was fixed at 1.0ml/min because of the good peak area and satisfactory retention time. The mobile phase is ACN, Methanol, and Water (35:50:15 v/v) was fixed due to a good symmetrical peak. So this mobile phase was used for the proposed study. The run time was selected to be 8 min because the analysis gave a peak. In the present investigation, a simple, sensitive, precise, and accurate RP-HPLC method was developed for the quantitative estimation of Metformin and Saxagliptin in bulk drug and pharmaceutical dosage forms. This method was simple since diluted samples are directly used without any preliminary chemical derivatization or purification steps. Metformin and Saxagliptin were freely soluble in ACN and methanol. ACN, Methanol, and Water (35:50:15 v/v) were chosen as the mobile phase. The solvent system used in this method was economical. The % RSD values were within 2 and the method was found to be precise. The results expressed in the Tables for the RP-HPLC method were promising. The RP-HPLC method is more sensitive, accurate, and precise compared to the Spectrophotometric methods. This method can be used for the routine determination of Metformin and Saxagliptin in bulk drugs and Pharmaceutical dosage forms.
REFERENCES
A. Raja Reddy*, E. Revanth, T. Rama Rao, Analytical Method Development & Validation for Simultaneous Estimation of Saxagliptin & Metformin in Combined Pharmaceutical Dosage Form By RP-HPLC, Int. J. of Pharm. Sci., 2024, Vol 2, Issue 12, 2995-2999. https://doi.org/10.5281/zenodo.14547253